期刊文献+

新型磁共振造影剂钆贝葡胺诊断肝细胞癌的价值及病理基础 被引量:4

Value of Gd-BOPTA Enhanced MR in Diagnosing Hepatocellular Carcinoma with Correlation of Pathology
下载PDF
导出
摘要 目的探讨具有双相增强作用的磁共振造影剂钆贝葡胺(gadobenate dimeglumine,Gd-BOPTA)诊断肝细胞癌(HCC)的价值及其MR表现的病理基础。方法33例(42个病灶)CT或超声检查疑有肝脏占位的患者,按以下顺序接受MRI常规轴位的T2WI和T1WI平扫、冠状的T2WI、3D磁共振胆胰管成像(MRCP)、Gd-BOPTA增强的轴位LAVA三期动态扫描(延时时间为15、55及90s)、2D-T1W增强扫描、LAVA延时扫描(5及10min)和肝胆期扫描(20、40及80min)。收集大体标本及病理切片,与磁共振表现进行对比分析。结果手术病理证实HCC诊断21例(27个结节)。包含动态期和肝胆期在内的综合MRI诊断HCC的敏感性、特异性及准确性分别为92.9%、93.3%和92.9%。①血液动力学期(动态及延迟期):HCC以“快进快出”强化表现为主(22个),少数呈动静脉期强化(4个)及均无强化(1个)。②肝胆期(排泄期):23个HCC结节呈均匀稍低信号;另外4个结节(3个高分化及1个中分化)呈非均匀稍低信号,其中散在云絮状或斑点状稍高信号,病理上见肿瘤细胞淤胆及含有胆汁的毛细胆管存在。结论双相作用的Gd-BOPTA增强MR检查既能反映HCC的血供特点,又能反映病灶内不同程度丢失正常肝细胞功能的病理基础,具有较好的诊断价值。 Objective To investigate the value of new double-phasic MR contrast agent (gadobenate dimeglumine, Gd-BOPTA) in diagnosis of hepatocellular carcinoma (HCC) with correlation of pathology. Methods MRI scan was performed on 33 patients suspected of having focal liver lesions by CT or ultrasonography. The MRI scan protocol included routine axial T1WI and T2WI, coronal T2WI and 3D-MRCP, Gd-BOPTA enhanced 3D gradientecho sequence of T1W (LAVA sequence) acquiring dynamic data at 15 s, 55 s and 90 s respectively, delayed LAVA acquisition at 5 min, 10 min, and at 40 min, 80 min respectively. Surgical specimen was collected for pathological analysis. Results Surgery confirmed the diagnosis of HCC in 21 patients with 27 lesions. The sensitivity, specificity and accuracy of MR imaging with combined phases (including hemodynamic phase and hepatobiliary phase) were 92.9%, 93.3%, 92.9% respectively. (1)In the hemodynamic phase: 22 lesions showed early enhancement in arterial phase, fast "washout" in portal venous phase, and hypointense in delayed phase. Four lesions showed slight enhancement, while 1 lesion showed no enhancement in all hemodynamic phases. (2)in the hepatobiliary phase: 23 le sions showed homogeneous hypointensity compared to the enhanced liver background, but 4 lesions (3 well-differentiated and 1 moderately-differentiated) had patchy or dot-like slightly hyperintense areas scattered within the lesions. Pathologically cholestatic changes of tumor cells were observed and bile-contalning small ducts were present. Conclusion Gd-BOPTA enhanced MRI can both depict the hemodynamic characteristics and reflect the absence of normal hepatocyte function in HCC lesions, thus contributing greatly to the diagnosis of HCC.
出处 《中国普外基础与临床杂志》 CAS 2007年第4期485-489,共5页 Chinese Journal of Bases and Clinics In General Surgery
基金 四川省科技厅应用基础研究项目(05JY029-005-05)
关键词 磁共振成像 肝细胞癌 MR造影剂 Magnetic resonance imaging Hepatocellular carcinoma MR contrast media
  • 相关文献

参考文献10

  • 1Ichikawa T,Kitamura T,Nakajima H,et al.Hypervascular hepatocellular carcinoma:can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?[J].AJR Am J Roentgenol,2002; 179(3):751
  • 2邬颖华,宋彬,徐隽,印隆林,毛芸.VIBE序列在原发性肝癌MRI诊断中的价值[J].中国普外基础与临床杂志,2005,12(2):184-187. 被引量:11
  • 3Kirchin MA,Pirovano GP,Spinazzi A.Gadobenate dimeglumine (Gd-BOPTA).An overview[J].Invest Radiol,1998; 33(11):798
  • 4Caudana R,Morana G,Pirovano GP,et al.Focal malignant hepatic lesions:MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase Ⅱ clinical application[J].Radiology,1996; 199(2):513
  • 5Vogl TJ,Stupavsky A,Pegios W,et al.Hepatocellular carcinoma:evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation[J].Radiology,1997; 205(3):721
  • 6Pirovano G,Vanzulli A,Marti-Bonmati L,et al.Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions[J].AJR Am J Roentgenol,2000; 175(4):1111
  • 7Kuwatsuru R,Kadoya M,Ohtomo K,et al.Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors[J].Invest Radiol,2001; 36(11):632
  • 8Hayashi M,Matsui O,Ueda K,et al.Progression to hypervascular hepatocellular carcinoma:correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material[J].Radiology,2002; 225(1):143
  • 9陈卫霞,闵鹏秋,周翔平,宋彬,刘燕,沈明恩,李真林,杨敏.肝细胞癌螺旋CT增强双期扫描边缘强化与病理对照研究[J].中华放射学杂志,2002,36(2):152-156. 被引量:42
  • 10Grazioli L,Morana G,Caudana R,et al.Hepatocellular carcinoma:correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings[J].Invest Radiol,2000; 35(1):25

二级参考文献16

  • 1汪剑,陆建平,田建明,王飞,刘崎,王莉,龚建国,金爱国,曾浩.3D-FS-FLASH序列在肝细胞癌MRI诊断中的应用价值[J].中国医学影像技术,2003,19(6):699-701. 被引量:2
  • 2Grazioli L,Olivetti L,Fugazzola C,et al.The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology.Eur Radiol,1999,9:62-67.
  • 3Hawighorst H,Knapstein PG,Knopp MV,et al.Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.Cancer Res,1998,58:3598-3602.
  • 4Suzuki K,Hayashi N,Miyamoto Y,et al.Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.Cancer Res,1996,56:3004-3009.
  • 5Cao G,Kuriyama S,Du P,et al.Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer.Gastroenterology,1997,112:501-510.
  • 6Leibovich SJ,Polverini PJ,Shepard HM,et al.Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha.Nature,1987,329:630-632.
  • 7Semelka RC,Hussain SM,Marcos HB,et al.Perilesional enhancement of hepatic metastases:correlation between MR imaging and histopathologic fingings-initial observations.Radiology,2000,215:89-94.
  • 8Liotta LA,Steeg PS,Stetler-Stevenson WG.Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation(Review).Cell,1991,64:327-336.
  • 9Yu JS,Kim MJ. Hepatocellular carcinoma:contrast-enhanced MRI [J]. Abdom Imaging,2002; 27(2):157.
  • 10Hussain SM,Zondervan PE,IJzermans JN,et al. Benign versus malignant hepatic nodules:MR imaging findings with pathologic correlation [J]. Radiographics,2002; 22(5):1023.

共引文献49

同被引文献41

  • 1杨军,严福华,周康荣,施伟斌,陈财忠,沈继章.肝局灶性结节增生的MRI表现[J].临床放射学杂志,2004,23(8):695-698. 被引量:13
  • 2陆伦根.胆汁淤积的发生机制和诊治策略[J].胃肠病学,2005,10(3):188-191. 被引量:12
  • 3黄国鑫,徐坚民,孙黎明,李肃,张景忠.肝脏局灶性结节增生的CT和MRI表现与病理对照研究[J].中国医学影像学杂志,2006,14(2):104-107. 被引量:17
  • 4郑列,吴沛宏,沈静娴,莫运仙,谢传淼,阮超美,李立.肝局灶性结节增生患者的典型与不典型螺旋CT征象分析[J].癌症,2006,25(7):861-865. 被引量:20
  • 5Semelka RC,Martin DR,Balci C,et al.Focal liver lesions:com-parison of dual-phase CT and multisequence multiplanar MR ima-ging including dynamic gadolinium enhancement[J].J Magn Re-son Imaging,2001,13:397.
  • 6Krinsky GA,Lee VS,et al.Transplantation for hepatocellularcarcinoma and cirrhosis:sensitivity of magnetic resonance ima-ging[J].Liver Transpl,2002,12:1156.
  • 7Marckmann P,Skov L,et al.Nephrogenic systemic fibrosis:sus-pected causative role of gadodiamide used for contrast-enhancedmagnetic resonance imaging[J].J Am Soc Nephrol,2006,17:2359.
  • 8Vitti RA.Gadolinium-based contrast agents and nephrogenic sys-temic fibrosis[J].Radiology,2009,250:959.
  • 9Shenoy C.Gadolinium-induced nephrogenic systemic fibrosis inpatients with kidney and liver disease[J].Am J Med,2008,121:11.
  • 10Thomsen HS.Imaging patients with chronic kidney disease:CINor NSF?[J].Radiol Med,2007,112(5):621.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部